Lauren E. Haydu

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Multi-sampling allows intra-tumoral heterogeneity querying and vulnerability profiling in glioblastoma

  Neuro-Oncology · 2026-06-15

• Empowering Neurosurgical Leadership: Training the Next Generation of Neurosurgical Leaders

  Neurosurgery · 2026-03-26

• Alliance A021901: Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor-Positive Bronchial Neuroendocrine Tumors

  Endocrine Abstracts · 2026-03-04

• The Impact of Lung and Heart Radiation Dose During Preoperative Chemoradiation on Overall Survival in Esophageal Cancer—A Post Hoc Analysis of CALGB 80803 (Alliance)

  International Journal of Radiation Oncology*Biology*Physics · 2026-02-06

• Functional genomics identifies therapeutic options, biomarkers, and resistance mechanisms for high-grade gliomas

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-02-03

• BRCA1 and BRCA2 carriers: Perceptions of endometrial cancer risk

  Gynecologic Oncology · 2026-01-30

• Retrospective analysis of cutaneous immune‐related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA‐B*51:01 allele

  Cancer · 2026-01-21 · 2 citations

• Editor’s Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

  Cancer Discovery · 2025-12-02

• Socioeconomic deprivation and medical comorbidity burden associations with clinicopathologic characteristics in an ethnoracially diverse Alzheimer's disease autopsy series

  Alzheimer s & Dementia · 2025-12-01

• Supplementary Tables 1 and 6-8 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S7 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S6 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S1 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Table 3 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Table 4 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S4 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S8 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Table 5 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Table 2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25